382 related articles for article (PubMed ID: 35209073)
1. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
[TBL] [Abstract][Full Text] [Related]
4. Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
Wang YT; Cheng TL
J Biomol Struct Dyn; 2016 Oct; 34(10):2214-23. PubMed ID: 26488313
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
[TBL] [Abstract][Full Text] [Related]
6. Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems.
Ali A; Gupta D; Srivastava G; Sharma A; Khan AU
J Biomol Struct Dyn; 2019 May; 37(8):2061-2071. PubMed ID: 29749296
[TBL] [Abstract][Full Text] [Related]
7. Recent research and development of NDM-1 inhibitors.
Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
[TBL] [Abstract][Full Text] [Related]
8.
Rahman M; Khan MKA
J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
[TBL] [Abstract][Full Text] [Related]
9. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
10. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and
Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
[TBL] [Abstract][Full Text] [Related]
13. Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections.
Grigorenko VG; Khrenova MG; Andreeva IP; Rubtsova MY; Lev AI; Novikova TS; Detusheva EV; Fursova NK; Dyatlov IA; Egorov AM
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163756
[TBL] [Abstract][Full Text] [Related]
14. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
[TBL] [Abstract][Full Text] [Related]
15. The role of conserved residues in the catalytic activity of NDM-1: an approach involving site directed mutagenesis and molecular dynamics.
Ali A; Kumar R; Iquebal MA; Jaiswal S; Kumar D; Khan AU
Phys Chem Chem Phys; 2019 Aug; 21(32):17821-17835. PubMed ID: 31373340
[TBL] [Abstract][Full Text] [Related]
16. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.
Wang X; Yang Y; Gao Y; Niu X
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443639
[TBL] [Abstract][Full Text] [Related]
17. Discovery of NDM-1 inhibitors from natural products.
Shi C; Chen J; Xiao B; Kang X; Lao X; Zheng H
J Glob Antimicrob Resist; 2019 Sep; 18():80-87. PubMed ID: 30763762
[TBL] [Abstract][Full Text] [Related]
18. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes.
Kamo T; Kuroda K; Kondo S; Hayashi U; Fudo S; Yoneda T; Takaya A; Nukaga M; Hoshino T
Chem Pharm Bull (Tokyo); 2021; 69(12):1179-1183. PubMed ID: 34853284
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation.
Shi C; Bao J; Sun Y; Kang X; Lao X; Zheng H
Bioorg Chem; 2019 Jul; 88():102953. PubMed ID: 31077911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
